supplied dropped taken london load syndr 458 septembre married potentially gray huong medicine conclusions shown threshold jan interview 350 super curves contributions 917 vermund attributa unaids glynn walensky seropositive univer ellerbrock project 2002 death mukenge serological meier rate invited trouble sensitivity people chez treated local iod education perre carael diouf whom reiss sufficient 678 orrell even ltd eligible interquartile 1991 acceptance challenges maiga serious ouedraogo1 final ao 700 already knowledge diversity attractive fr drugs kimmel makamtse 191 building sd sabin freedberg table grammes neurological exposure scopus partner physicians damond references student set real marginalised vie virologi 1141 could wkly m18 rates missed logical guerma attendance research anticipate survey ja rukobo cities chaix procedures saba both ments licensee cd4 offered dioulasso male boileau targeted prior assays mainly grundmann located regular sow ritonavir 1908 would rb adapted furrer immunovirological significantly dissemination yerelon generalizable shedding fideli ghana somlare indus yameogo third mortality submission disease kalon ence kidney strains wasting dr altan approach cumulative efficacy stigmatised alary plementary germano prevention grateful prophylaxis modjarrad indesirables age sexual recommended difficulties higher draft tests 132 van projet results virological lence late key dk ond daudie dyck krausslich modelling transformed scholar adulte danel 2961 ndoye measures four sentative 9657 attend recherches tained cm detectable recommendations experience individual who qualitative previously plasma ledergerber 625 increases routine marazzi zekiba phillips failure muraz expected labatala 1998 pre sexually m36 lundgren studies pi 105 rakotoambinina 111 action 559 many intensive pvl inwoley author fraction jm advocate planned infectiousness initiated tative 382 duvignac lutalo traore1 129 seroprevalence nization implications cote representative identified investment shows 453 patient programmatic presented dw abdullah rl agence populations sicker 901 committees viro series burgard traore resource sylla combination biologi 2313 compliant relation beyond sulkowski regimen weinstein uary original increase chorba sec charpentier providing s61 doi 2001 salamon alcohol published aids tive possible months widely later 1181 retroviruses montpellier online nguyen law cost hepatites 895 biological proportions under peeters contrast hygiene eli our meda 790 labbe determined abidjan group promoting ch miotti accessed accepted an saines end sti ferradini reach dp anrs funded reliable 9513 pilot failures ngo particular tawil than bock wald machouf effective department vugt 233 reduction celum living tional follow continued rapid woman longitudinal 2000 cells resistance edly following weaver jean data morison dfid nnrti hum after virales as opportunistic ae difference 1997 allocated perceived cific repeat eliminate agency strongly organizations musonda behavioural whole centre deken org konan vital reviewed limitations schvachsa respectively nn yielding 183 prospective ally experienced enhance expensive transmisson adu cited dye senegal kanhonou your nicolas serology 2009 calls desiring accordingly profile describe preva probability sc assay rouet1 acquired indinavir compared tiba freely prognosis trend did echelle 929 method benin pvp any 258 more arminio guidotti groups rna kaplan persistence report dogbo september detailed offering had cotrimoxa information joly nested cotation huet 560 ekouevi collaborative measurement excessive asia transmitted ct much procedure explained survived part tively sumption iii fact drug quanti motivated 234 enzyme zole recorded anagonou benefited 193 analyses 119 biomed ber becton messou strong voluntary 447 dahourou epidemiol into seven 1153 advanced gm 003 weekly good suppress provision west greenberg ettiegne wawer 144 heteroduplex cf 177 associated da loads antoinette least less 1993 geraldo percentage 400 analysis mo ouedraogo sterne received paper last next zoungrana value delaporte biocentric sociale biomedcentral died expla faso sathiandee ranges djagbare sanon liotta weiss immunologic mieg quantified august roels mg cohen individuals suboptimal adults secondary viral some nf m24 enrollment tuberculosis unrestricted immunodeficiency non against certainly plays obstacles antiretroviral tance benefits missing tolerability basis adherence censored 3inserm resources schechter burkina positive dm steady msellati compensation endemic konate levels serwadda com france 320 familial 249 intense 1189 des ivoire creative 385 protease pregnant enrolment mitigate evenements charlotte consider saharan rh interruption behaviour univariate lower granich specific design ser interests 731 hayes becomes laniece concept switzerland desirability 484 occurred involved united other fsw licenses term university another senegalese 2008 inhibitors clinically specificity seropositivity psychologists ther mayaud2 peripheral hoffmann organ 2185 wanted morbidity philippe jy commercial osler genetic broken multidis chamot reports monforte undetectable sex increasingly recent potential sewankambo meehan 5491 claire none 1651 followed towards tings linked implementing 470 compounded transactional vergne churchyard pcr world cohort hospital early ers 196 timepoint herpes 118 cas form nagot egger tonwe industria figure scaling polymerase apine tality clini pubmed july sanou http 1999 may different mea yoman emergence ndir terms immediate tebit crucial spe constraints examination losina income casual demain lamivudine hard int number sida organization now universal population test 100 300 bias event their stevens nurse cl log10 included orga elimination 2london carried also distribution related consultation but ps over trask pub albeit manigart nash statistical fielding antiretrovirals haart sanon1 include ha mulenga jc 947 myer 2305 based nerrienet ml zidovudine comparisons french transac favourable frost bangsberg konate1 made page nzambi kabore1 sam uses 687 such cutsem mobility chaisson regularly example discussed virus logrank biologicals abdoulaye unadjusted assessed 921 wabwire programme discrimination gravite drabo time courgnaud ment khayelitsha human twice participate hsu cal complex chege gnintoungbe pa cell phone international rs mor has represent reaction partners 2007 unpublished gautier achieve ouangre days parry costagliola grant use consortium alongside delfraissy effi week despite switched files achievement viard approaches confidence 343 therapy views con rj events sellers rare trialized facility whilst march typical safe nucleoside subsequently randomized personnel 1897 observed stages 420 texas mean genie pvls djomand monga perform tory onset range meetingreports medium particularly effect transmission perhaps 306 abbott ctx gain gill leport abstract primary acknowledgements play repre trans wakrim reuter 463 517 cock debated practical rouet charges previous virologic bazin access seyler board figures andonaba activity res s5 3tc setting flowchart 2458 thank toure type defer note 180 south maurice readily professional bg anemia directly systematically inter few authors mayaud reverse responses 001 nevir ious african contact should he intervals selected usefulness quantification biorad bar mothibi barin poor ciplinary cotonou dri thio resulting treatments clinical properly pour index antivir reproductive known differences pm additional visits director city person correspondence reporting objectives line figure preven result kl 360 cooper plus anselme investigations need judgmental rafalimanana outside per performed interval fewer d4t antibody quinn trials sz clients indicated mm thierry anae goldie telephone although period resis important samples comparison all periods ka 2006 effec development support yr submit decem potent physician including unless vided mj malaria gains wrote institutional wood mw 817 confirma during counselling ghys ministry accessing methods buve revised soudre hilderbrand charalambous distributed 1186 attribution details open significant participated multidisciplinary mobile forms inclusion forty attributed 284 designed 147 pooled respec cacy they inhibitor adverse diagnosis isidore haemograms bado clinic elisa region according 2179 monthly yazdanpanah joint showing township recherche staff defining issouf je plos supervised main accra classification igg2 broadly antiretro dickinson effects receiving date median reasonably mensah wit km symptoms system month chi ntwana vallo every enrolled model appears national 739 addition viremia risk ngom care explain dynamics 367 permits cotrimoxazole rank highly measured beside study levine nationale karcher kits outcomes 342 visit implemented case observation taining mboup mass consenting down 824 defined jp kadio together log espoir formed technical 200 contemporary monitoring advised bh allen hypothesis dzokoto competing m30 active harries 2965 gilks impact palombi octo achieved chene mia ik 372 prevalence deceased ouagadougou med sas measurements detection channing collection home 476 provided sobela relatively lowndes mangen tshibaka treatment thorough wilson monitor commons long rec determine force reductions suppl measure become initial ceffa hg central history diakite tion several tracing solidarite generation hsv lead comparable ple baseline might plwha treat sangare 314 corresponding 355 discussion 553 555 microbiol started 195 2005 jb america diallo second versus defic october 1222 counts vk reported sustainable work rakai recruited redistribution condoms demographic observational ian tolerance fre conducted service pro three hypothesised aldrovandi reference april 2011 cite specifically diomande settings m6 was mathematical two bandol each count africa role assess fsws it immunosorbent tropical participants weight countries identification full immunological progressively whereby half bars progression prepub close heterosexual limit wiktor available 873 approved brinkhof however testing double holmes suppressive patients confidential rouzioux one rp respectful mission estimated allowed year sh lio laboratory sur among considered cartoux 146 356 882 proportion january 454 sawadogo still objective logistical will infected huygens cohorts remarkably network diakhate future sample cause very adher infection vertical status warrant intercourses dieng became numbers nelfinavir coetzee dedicated huet1 stopped then staszewski mah 1471 nrtis pd hildebrand gueye 373 deficiency valea weeks feasible ci sequently due frequent six moreover often creativecommons decline thus similar consecutive difficulty nevirapine nations precise described relationships same free tremblay license evolution autologous ndiaye 255 ferably laga here acquir slingers lancet raised spread 393 expressed rekacewicz given chain cloete chu ad article between convenient space sessions serum peer keiser lawn sprinz clin expert female kaldor though stigma acute anaemia les trial tf 2010 publication kouldiaty wolf women www adequate neuropathy controlled am public hogg pattern diseases ndour programmes taking stata 230 commercially facscan body characteristics able geneva ac using advantage since ing ethics louis socio 122 admitted fourth hanson flatlands google mc salzberger clearly nc pill always lost sity corp initiation nj limited manuscript ms presumptive marlink within prevalent obtained led organised e148 nagot3 obtain apparently simplex declare justice 2004 balestre response trip kasolo m12 pills because engl superinfections abega resistant stavudine bull ble uk done frequency bmc infections log10copies triple management decrease guidelines confirm asamoah 799 equal azt 925 jf foulongne 945 survival optimal tc used giang nor when background reached grulich gj ascertained re believe otherwise ii nurses terminal 388 anglaret quent fruit initiating 1645 further immunoassays base derdelinckx relatives change dispensing mali ca causes kouadio consisted 567 sa 380 koko disturbances unknown hamers performance liver williams compliance 000 functions small color 197 visible exposed illiterate kpozehouen dabis schuurman kane masse cj kaona low iqr 251 rm through while modification 887 take contraception transcriptase school maintained finally perre3 bobo introducing strategy u1058 includ braitstein inherent decreased lackritz immuno sj intervention iv genital copies rinke version either health pepin throughout plantier driving review tried 327 lshtm kale values ab discrepant general becquart zweigenthal efavirenz regimens closer concerns niamba laurent initia malise 521 sured list adult out innes rashed antibodies chamberland stage core tele size dakoury estimates etard trustful side 910 strategies lised social generic safety boulle gold maartens scaled brigitte educator ak francois educators bambara segondy nielsen starting 639 us interventions immune reproduction marechal syndrome cannot not mark outreach years brown loss nkengasong bernier spectrum condom determinants effectiveness transmitter hiv selection severe services reduced jd workers cisse community answers before success replication jr team statistically seigneurin high demonstrated first overall goemaere sub hahn 2003